This inventor holds 1 USPTO granted patent. Top assignees: Centre Leon Berard, Hospices Civils De Lyon, National Institute of Health and Medical Research. Active years: 2008.
Company Filing History:
1 out of 39 
1 out of 46 
1 out of 1,853 
Years Active: 2008
Title: The Innovative Contributions of Laurent Alberti
Introduction
Laurent Alberti is a notable inventor based in L'Arbresle, France. He has made significant contributions to the field of medicinal proteins, particularly in the context of cancer treatment. His work focuses on proteins with IL-6 inhibiting activity, which have the potential to serve as effective anti-cancer agents.
Latest Patents
Laurent Alberti holds a patent for "Proteins with IL-6 inhibiting activity." This invention concerns proteins that inhibit IL-6 and their use as medicinal products, specifically targeting cancer treatment. The patent highlights the use of proteins containing at least the amino acid sequence SEQ ID NO. 4, showcasing the innovative approach to combating cancer through molecular biology.
Career Highlights
Throughout his career, Laurent Alberti has been associated with prestigious institutions such as Université Claude Bernard Lyon 1 and Centre Léon Bérard. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
One of his notable collaborators is Jean-Yves Blay, with whom he has worked on various projects related to cancer research and treatment. Their partnership has furthered the understanding of IL-6's role in cancer and the development of targeted therapies.
Conclusion
Laurent Alberti's innovative work in developing proteins with IL-6 inhibiting activity represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in the pursuit of effective medical solutions.